Skip to content

Study of miR-25 detection optimized by a nanoprobe in the diagnosis of ischemic stroke

Application of a Nanoprobe Optimized Non coding RNA Detection in Clinical Practice

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085976
Enrollment
Unknown
Registered
2024-06-21
Start date
2024-06-24
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Interventions

Gold Standard:Detection of miR-25 by qRT-PCR in peripheral blood
Index test:Fluorescence intensity detection of miR-25 optimized by the nanoprobe in peripheral blood

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Ischemic stroke and sampling within 6 hours after symptom onset; 2. showing National Institute of Health Stroke Scale (NIHSS) score on the scale<25, 3. patients with only focal neurological issues without any signs of hemorrhage on CT scan.

Exclusion criteria

Exclusion criteria: 1. Confirmation of malignancy, liver disorder, renal failure, or hematologic disorder, 2. Mental disorders or heart diseases, 3. any other disorder found to affect the hemogram.

Design outcomes

Primary

MeasureTime frame
fluorescence intensity detection of miR-25;

Secondary

MeasureTime frame
accuracy;specificity;sensitivity;ROC;

Countries

China

Contacts

Public ContactJiansheng Su

Fujian Medical University Union Hospital

sjs2028@163.com+86 180 5914 3208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026